PTPLAD2 inhibitors are small molecules that specifically target the protein tyrosine phosphatase-like A domain-containing protein 2 (PTPLAD2), an enzyme associated with various cellular processes including lipid metabolism, protein folding, and signal transduction. These inhibitors are designed to bind to the active site or regulatory domains of PTPLAD2, thereby modulating its enzymatic activity. PTPLAD2 is part of a larger family of phosphatases and phosphatase-like proteins that are integral to cell regulation and homeostasis. Unlike classical protein tyrosine phosphatases that directly dephosphorylate tyrosine residues, PTPLAD2 possesses a phosphatase-like domain but may not exhibit conventional phosphatase activity, which positions its inhibitors as potential tools for studying non-canonical pathways. The specific chemical structures of PTPLAD2 inhibitors often feature motifs that facilitate interaction with the protein's binding pockets, such as aromatic rings, hydrophobic chains, and heterocyclic groups that optimize binding affinity and selectivity.
Structurally, PTPLAD2 inhibitors are diverse, and their design is typically guided by a combination of high-throughput screening, structure-based drug design, and optimization for binding efficacy. The inhibitors can be reversible or irreversible, depending on the nature of their binding interactions with PTPLAD2. For instance, certain inhibitors may form covalent bonds with key amino acid residues within the active site, resulting in a more permanent modification of PTPLAD2 function. Others may rely on non-covalent interactions such as hydrogen bonds, hydrophobic effects, and van der Waals forces, allowing for transient modulation of PTPLAD2 activity. PTPLAD2 inhibitors are valuable research tools in chemical biology and biochemistry, enabling detailed investigation of PTPLAD2's role in cellular processes. By inhibiting PTPLAD2, researchers can elucidate its function within complex signaling networks, study its interactions with other cellular proteins, and explore its involvement in various biochemical pathways, thus contributing to a broader understanding of cellular regulation and enzyme dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
A potent inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), which could reduce phosphatase activity, affecting PTPLAD2-related pathways. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
A toxin that inhibits PP1 and PP2A, similar to okadaic acid, potentially altering the phosphorylation state of proteins in PTPLAD2-related signaling. | ||||||
Fostriecin | 87860-39-7 | sc-202160 | 50 µg | $265.00 | 9 | |
Selectively inhibits protein phosphatase 2A (PP2A) and could alter signaling cascades where PTPLAD2 is a regulator. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
An inhibitor of protein phosphatases, particularly PP2A and PP1, potentially modifying the phosphatase-regulated pathways involving PTPLAD2. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $49.00 $203.00 | 1 | |
Acts as a protein phosphatase inhibitor and could disrupt the balance of phosphorylation, affecting PTPLAD2 functions indirectly. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore, which can increase intracellular calcium and indirectly affect PTPLAD2 by modulating calcium-dependent phosphatase activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
A protein kinase C inhibitor, potentially affecting downstream targets of PTPLAD2 by altering kinase/phosphatase balance. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Inhibits the phosphatase activity of calcineurin, potentially impacting PTPLAD2-related signaling by shifting the phosphorylation state of the network. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
Binds to FKBP12 and inhibits calcineurin, similar to cyclosporin A, affecting PTPLAD2 activity by altering the cellular phosphatase activity. | ||||||
Pramoxine hydrochloride | 637-58-1 | sc-264141 | 10 g | $44.00 | ||
An inhibitor of tyrosine phosphatases, which could alter signaling pathways related to PTPLAD2 by changing the phosphorylation state of proteins. | ||||||